secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0001104659-24-044766
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt plc dismisses Deloitte as auditor, appoints PwC
------------------------------------------------------------

- Dismissed Deloitte & Touche effective April 3, 2024; engaged PricewaterhouseCoopers for FY ending Dec 27, 2024.
- No disagreements with Deloitte of the type under Item 304(a)(1)(iv) during audit periods or through April 3, 2024.
- No reportable events under Item 304(a)(1)(v) occurred during same periods.
- Deloitte's audit reports on prior financials contained no adverse opinion or qualification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000110465924044766/0001104659-24-044766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000110465924044766/tm2411283d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-044766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer